A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Luckily for you, we built StockStory to help you separate the good from the bad. That said, here are three cash-producing companies that don’t make the cut and some better opportunities instead.
Agilysys (AGYS)
Trailing 12-Month Free Cash Flow Margin: 21.3%
With a tech stack that powers everything from check-in to checkout at some of the world's top hospitality venues, Agilysys (NASDAQ: AGYS) develops and provides cloud-based and on-premise software solutions for hotels, resorts, casinos, and restaurants to manage operations and enhance guest experiences.
Why Is AGYS Not Exciting?
- Gross margin of 62.6% reflects its relatively high servicing costs
- Operating profits increased over the last year as the company gained some leverage on its fixed costs and became more efficient
Agilysys is trading at $82.73 per share, or 6.1x forward price-to-sales. If you’re considering AGYS for your portfolio, see our FREE research report to learn more.
America's Car-Mart (CRMT)
Trailing 12-Month Free Cash Flow Margin: 1.1%
With a strong presence in the Southern and Central US, America’s Car-Mart (NASDAQ: CRMT) sells used cars to budget-conscious consumers.
Why Do We Steer Clear of CRMT?
- Disappointing same-store sales over the past two years show customers aren’t responding well to its product selection and store experience
- Issuance of new shares over the last three years caused its earnings per share to fall by 31.2% annually
America's Car-Mart’s stock price of $12.86 implies a valuation ratio of 21.4x forward EV-to-EBITDA. Dive into our free research report to see why there are better opportunities than CRMT.
Thermo Fisher (TMO)
Trailing 12-Month Free Cash Flow Margin: 14.9%
With over 14,000 sales personnel and a portfolio spanning more than 2,500 technology manufacturers, Thermo Fisher Scientific (NYSE: TMO) provides scientific equipment, reagents, consumables, software, and laboratory services to pharmaceutical, biotech, academic, and healthcare customers worldwide.
Why Does TMO Fall Short?
- Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion
- Expenses have increased as a percentage of revenue over the last five years as its adjusted operating margin fell by 6.7 percentage points
- Incremental sales over the last five years were less profitable as its earnings per share were flat while its revenue grew
At $486.44 per share, Thermo Fisher trades at 18x forward P/E. Check out our free in-depth research report to learn more about why TMO doesn’t pass our bar.
Stocks We Like More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
